Literature DB >> 13356423

The effects of intravenous apresoline (hydralazine) on cardiovascular and renal function in patients with and without congestive heart failure.

W HOLLANDER, W E JUDSON, R W WILKINS.   

Abstract

Entities:  

Keywords:  CONGESTIVE HEART FAILURE/complications; HYDRALAZINE/therapeutic use; HYPERTENSION/etiology and pathogenesis

Mesh:

Substances:

Year:  1956        PMID: 13356423     DOI: 10.1161/01.cir.13.5.664

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  11 in total

1.  Cardiac, hemodynamic and renal functions in congestive heart failure during induced peripheral vasodilatation; relationship to Starling's law of the heart in man.

Authors:  B J SOBOL; R H KESSLER; B RADER; L W EICHNA
Journal:  J Clin Invest       Date:  1959-03       Impact factor: 14.808

2.  [Effect of peroral prolonged therapy with 1,4-dihydrazinophthalazine on circulation and reflex changes in dogs].

Authors:  V EHRLICH; K FRONKOVA; L SLEGR
Journal:  Arch Kreislaufforsch       Date:  1958-09

3.  Current drug therapy of essential hypertension in relation to some of the non-renal factors which participate in the maintenance of blood pressure.

Authors:  S LOCKET
Journal:  Postgrad Med J       Date:  1957-03       Impact factor: 2.401

Review 4.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

Review 5.  Use of serum creatinine concentrations to determine renal function.

Authors:  T D Bjornsson
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

6.  Antihypertensive drug therapy.

Authors:  F O Simpson
Journal:  Drugs       Date:  1973       Impact factor: 9.546

7.  Post-hydralazine renin release in the diagnosis of renovascular hypertension.

Authors:  J A Mannick; A Huvos; W E Hollander
Journal:  Ann Surg       Date:  1969-09       Impact factor: 12.969

8.  Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure.

Authors:  S K Mujais; F M Fouad; S C Textor; R C Tarazi; E L Bravo; N Hart; R W Gifford
Journal:  Br Heart J       Date:  1984-07

9.  Autoradiographic study of the distribution of [3H]- and [14C]-hydrallazine in the rat.

Authors:  J R Baker; G R Bullock; I H Williamson
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

Review 10.  Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations.

Authors:  W J Remme
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.